Latest Regulatory Progress News

Page 2 of 58
Battery Age Minerals advanced its Bleiberg germanium permits and expanded Falcon Lake to about 60 km², but its cash position now covers an estimated 1.34 quarters of funding. Initial Apex fieldwork also failed to confirm the remote-sensing anomalies that had defined the Utah targets.
Victor Sage
Victor Sage
30 Oct 2026
Vectus Biosystems has secured FDA acceptance of a pre-IND Type B meeting for VB0004, a key regulatory step for its idiopathic pulmonary fibrosis programme. The biotech ended September with $410,000 in cash and reported estimated funding for just 1.33 quarters of operations.
Ada Torres
Ada Torres
29 Oct 2026
D3 Energy has expanded its South African acreage and secured Strategic Integrated Project status after drilling two gas-bearing wells at Nooitgedacht. A 5.2% helium sample is encouraging, but production testing, methane retesting and funding remain unresolved.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Finder Energy has secured the principal regulatory approvals for its Timor-Leste oil development and confirmed 22.2 MMstb of gross 2P reserves for the initial three wells. A conditional rig contract and advancing debt process move the project closer to FID, but financing, joint venture approvals and major contracts remain outstanding.
Victor Sage
Victor Sage
29 Oct 2026
Australis Oil & Gas has moved its first carried Tuscaloosa Marine Shale well closer to drilling, with contracts largely awarded and permits approved for two follow-on wells. A rig remains the key unresolved item before the targeted Q4 2026 spud.
Victor Sage
Victor Sage
29 Oct 2026
Lake Resources has moved its Kachi lithium project into front-end engineering after securing Catamarca’s Environmental Impact Declaration. A A$7.9 million ATM raising lifted quarter-end cash to A$10.1 million, although final capital costs and construction funding remain unresolved.
Maxwell Dee
Maxwell Dee
29 Oct 2026
OncoSil Medical delivered sharper commercial growth and a string of regulatory milestones in FY26, but the oncology device company remains heavily loss-making and dependent on future sales or fresh capital. Revenue rose 44% to $1.68 million while operating cash outflow reached $10.47 million.
Victor Sage
Victor Sage
27 Oct 2026
Minerals 260 has strengthened the funding and development position of its Bullabulling gold project, reporting approximately A$600 million of pro forma cash and a definitive feasibility study still targeted for Q1 2027. The company has also completed initial grade-control drilling, expanded its mining tenure and advanced village and water infrastructure.
Maxwell Dee
Maxwell Dee
27 Oct 2026
Echo IQ’s FDA-cleared EchoSolv AS platform processed 9,697 full-result assessments in the September quarter, while the company ended the period with A$107.8 million in cash. The stronger balance sheet gives it room to pursue US enterprise deployments, but commercial conversion and the unresolved EchoSolv HF regulatory pathway remain the key tests.
Victor Sage
Victor Sage
26 Oct 2026
Key Petroleum recorded no exploration, development or production activity in the September quarter as eight Queensland applications remained undecided. A A$247,053 placement lifted cash to A$329,410, but the company’s own funding estimate points to a limited runway on current outflows.
Victor Sage
Victor Sage
26 Oct 2026
Brookside Energy is expanding beyond its operated SWISH program with five proposed non-operated horizontal wells across three Oklahoma plays. The estimated US$3.5 million investment is intended to add future production and cash flow without drawing on a new equity issue.
Victor Sage
Victor Sage
21 Oct 2026
Recce Pharmaceuticals says a review of blinded Phase 3 data for its RECCE 327 Gel showed strong efficacy and a positive safety profile. An independent committee is expected to assess unblinded data from 75 patients as soon as mid-November, while recruitment continues.
Ada Torres
Ada Torres
20 Oct 2026

Browse the archive

Full archive